8.94

3.83% 0.33

Electra Therapeutics, Inc. Common stock (ETRA)

Overview News Price History Discussions Forecast

Electra Therapeutics, Inc. Common stock stock is traded at $8.94, with a volume of 521.07K. It is up +3.83% in the last 24 hours and up +0.00% over the past month.

Previous Close:

$8.61

Open:

$8.69

24h Volume:

521.07K

Relative Volume:

0.93

Market Cap:

$561.14M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-2.19%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$0.00

1-Week Range:

$8.50

$9.80

52-Week Range:

$8.50

$15.50

Electra Therapeutics, Inc. Common stock Stock (ETRA) Company Profile

Name

Electra Therapeutics, Inc. Common stock

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

ETRA's Discussions on Twitter

Compare ETRA vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ETRA Electra Therapeutics, Inc. Common stock	8.94	561.14M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	508.38	128.85B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	237.63	94.87B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	799.99	82.36B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	849.57	53.43B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	371.40	42.01B	5.76B	514.49M	1.10B	4.4813

Electra Therapeutics, Inc. Common stock Stock (ETRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-26	Initiated	Cantor Fitzgerald	Overweight
Oct-13-26	Initiated	Evercore ISI	Outperform
Oct-13-26	Initiated	Jefferies	Buy
Oct-13-26	Initiated	TD Cowen	Buy

Electra Therapeutics, Inc. Common stock Stock (ETRA) Latest News

Sep 28, 2026

Two entities report shared voting power over more than 5% of Electra Therapeutics (ETRA). - Stock Titan

Sep 28, 2026

An investment manager reports a stake above 5% in Electra Therapeutics (ETRA) after its IPO. - Stock Titan

Sep 28, 2026

Sep 25, 2026

OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake - TradingView

Sep 25, 2026

Two funds bought Electra Therapeutics (ETRA) IPO shares at $15. OrbiMed reports their stake. - Stock Titan

Sep 25, 2026

Sep 24, 2026

Total common shares outstanding of Electra Therapeutics, Inc. – NASDAQ:ETRA - TradingView

Sep 24, 2026

Sep 23, 2026

Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com Nigeria

Sep 23, 2026

ETRA SEC Filings, Sep 18, 2026Electra Therapeutics, Inc. Filing Archive - stocktitan.net

Sep 23, 2026

Form 4 Electra Therapeutics For: 23 September By Investing.com - Investing.com South Africa

Sep 23, 2026

A $15 IPO brought share purchases and preferred-stock conversions at Electra Therapeutics (ETRA). - Stock Titan

Sep 23, 2026

At $15 a share, OrbiMed funds bought Electra Therapeutics (ETRA) stock as preferred shares converted. - Stock Titan

Sep 23, 2026

Total common shares outstanding of Electra Therapeutics, Inc. – BOATS:ETRA - TradingView

Sep 23, 2026

Electra Therapeutics, Inc. Statistics – NASDAQ:ETRA - TradingView

Sep 23, 2026

OrbiMed Discloses Preferred Stock Conversion and Significant IPO Share Acquisitions in Electra Therapeutics - Kalkine Media

Sep 23, 2026

Sep 21, 2026

[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - Stock Titan

Sep 21, 2026

Electra Therapeutics (ETRA) director converts 255K preferred in IPO - Stock Titan

Sep 21, 2026

Electra Therapeutics (ETRA) CEO converts preferred stake into 455,484 common shares tied to IPO - Stock Titan

Sep 21, 2026

Electra Therapeutics (ETRA) Stock Price, News & Analysis - Stock Titan

Sep 21, 2026

[Form 4] Electra Therapeutics, Inc. Insider Trading Activity - stocktitan.net

Sep 21, 2026

Sep 19, 2026